Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DMAC

DiaMedica Therapeutics (DMAC)

DiaMedica Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DMAC
DateTimeSourceHeadlineSymbolCompany
05/19/20225:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
05/04/20224:42PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
05/04/20224:32PMBusiness WireDiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
04/28/20228:15AMBusiness WireDiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022NASDAQ:DMACDiaMedica Therapeutics Inc
04/05/20226:07AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DMACDiaMedica Therapeutics Inc
03/14/20224:59PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
03/14/20224:45PMBusiness WireDiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial ResultsNASDAQ:DMACDiaMedica Therapeutics Inc
03/08/20228:13AMBusiness WireDiaMedica Therapeutics to Report Fourth Quarter 2021 Financial Results and Provide a Business Update March 15, 2022NASDAQ:DMACDiaMedica Therapeutics Inc
02/15/20222:26PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DMACDiaMedica Therapeutics Inc
02/11/20224:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
02/11/20222:20PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DMACDiaMedica Therapeutics Inc
02/02/20224:38PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMACDiaMedica Therapeutics Inc
02/02/20228:43AMBusiness WireDiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial OfficerNASDAQ:DMACDiaMedica Therapeutics Inc
01/25/20228:43AMBusiness WireDiaMedica Therapeutics to Present Research at International Stroke ConferenceNASDAQ:DMACDiaMedica Therapeutics Inc
01/05/20224:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
01/05/20224:49PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DMACDiaMedica Therapeutics Inc
01/03/20224:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
12/22/202112:26PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DMACDiaMedica Therapeutics Inc
11/10/20214:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
10/15/20216:38AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DMACDiaMedica Therapeutics Inc
10/15/20216:33AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DMACDiaMedica Therapeutics Inc
10/08/20214:18PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMACDiaMedica Therapeutics Inc
10/06/20214:20PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DMACDiaMedica Therapeutics Inc
10/06/20216:01AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DMACDiaMedica Therapeutics Inc
10/05/20215:02PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:DMACDiaMedica Therapeutics Inc
09/27/20218:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
09/13/20214:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
08/17/20214:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
08/17/20214:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DMACDiaMedica Therapeutics Inc
08/11/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DMACDiaMedica Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DMAC